| Mrs Elizabeth C Valenti, RPH | |
|
49 Marty Drive, Merrimack, NH 03054 | |
| (603) 424-8833 | |
| Not Available |
| Full Name | Mrs Elizabeth C Valenti |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 49 Marty Drive, Merrimack, New Hampshire |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1497073621 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 2533 (New Hampshire) | Primary |
| 183500000X | Pharmacist | 19986 (Massachusetts) | Secondary |
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Elizabeth C Valenti, RPH 49 Marty Drive, Merrimack, NH 03054 Ph: (603) 424-8833 | Mrs Elizabeth C Valenti, RPH 49 Marty Drive, Merrimack, NH 03054 Ph: (603) 424-8833 |
News Archive
A novel risk score may help physicians decide whether to admit or discharge patients who present to the emergency department with an acute episode of heart failure, say its developers.
Despite a broad campaign among physician groups to reduce the amount of imaging in medicine, the rates of use of CT, MRI and other scans have continued to increase in both the U.S. and Ontario, Canada, according to a new study of more than 135 million imaging exams conducted by researchers at UC Davis, UC San Francisco and Kaiser Permanente.
Watson Pharmaceuticals, Inc., a leading global specialty pharmaceutical company, today confirmed that its subsidiary, Watson Laboratories, Inc.-Florida, filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration seeking approval to market its 8mg ramelteon tablets prior to the expiration of a patent owned by Takeda Pharmaceutical Company Limited.
Precision Dynamics-TimeMed, the global leader in healthcare identification solutions, announced today that it has been awarded a combined contract for healthcare wristbands and labels by MedAssets, one of the nation's largest group purchasing organizations (GPOs).
Precision medicine is a focus of ongoing debate. In an environment of limited research funds, there are those who believe that precision medicine should be funded because it will improve population health, and those who feel that it shouldn't, because it won't.
› Verified 2 days ago
Gregory Vestal, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 570 Daniel Webster Hwy, Merrimack, NH 03054 Phone: 603-424-4519 | |
Stephen James Deminico, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 615 Daniel Webster Hwy, Merrimack, NH 03054 Phone: 603-423-9330 Fax: 603-423-9336 | |
Lauren Herrick West, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 570 Daniel Webster Hwy, Merrimack, NH 03054 Phone: 603-424-4519 | |
Renan Moretta, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 416 Daniel Webster Hwy, Merrimack, NH 03054 Phone: 603-424-4833 Fax: 603-424-4578 | |
Mr. Brad A Valenti, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 7 Continental Blvd, Merrimack, NH 03054 Phone: 603-429-0759 Fax: 603-429-0813 | |
Dr. Meghan Armstrong, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 456 Daniel Webster Hwy, Merrimack, NH 03054 Phone: 603-424-1120 | |
Nancy Delaney, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 456 Daniel Webster Hwy, Merrimack, NH 03054 Phone: 603-424-1120 |